Evicenter
P&T meetings

Zanzalintinib (XL092)

Metastatic colorectal cancer

Manufacturer
Exelixis
Regulatory submission
NDA submitted December 2025
Launch
Not announced
Last updated
65 sources

Product information and disease descriptionPlace of product in therapyDisease description

Clinical presentation - signs and symptoms

3 evidence topics · 1 source

Bowel symptoms: change in bowel habits

“A change in bowel habits.” (opens the source at this quote in a new tab)

Bleeding: blood in the stool

“Blood in or on your stool (bowel movement).” (opens the source at this quote in a new tab)

Pain: persistent abdominal symptoms

“Abdominal pain, aches, or cramps that don't go away.” (opens the source at this quote in a new tab)